COSMOS Pharmaceutical Corporation (TYO:3349)

Revenue by Segment

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Retail Business of Pharmaceuticals and Cosmetics	1.10T	1.01T	964.99B	827.70B	755.41B
Total	1.10T	1.01T	964.99B	827.70B	755.41B

Revenue by Geography

Financials in millions JPY. Fiscal year is June - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017
Japan	1.10T	1.01T	964.99B	827.70B	755.41B
Total	1.10T	1.01T	964.99B	827.70B	755.41B

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error